Suppr超能文献

吲哚衍生物作为治疗神经退行性疾病的双重有效药物:合成、生物评价和分子模拟研究。

Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.

机构信息

Dipartimento di Scienze del Farmaco e dei Prodotti per la Salute, Università di Messina, Viale Annunziata, Messina I-98168, Italy.

出版信息

Bioorg Med Chem. 2013 Aug 1;21(15):4575-80. doi: 10.1016/j.bmc.2013.05.044. Epub 2013 Jun 2.

Abstract

Several indole derivatives, that were highly potent ligands of GluN2B-subunit-containing N-methyl-D-aspartate (NMDA) receptor, also demonstrated antioxidant properties in ABTS method. In particular, the 2-(4-benzylpiperidin-1-yl)-1-(5-hydroxy-1H-indol-3-yl)ethanone (1) proved to be a dual-effective neuroprotective agent. With the aim to increase the antioxidant properties we added a catechol moiety onto piperidine moiety. The designed hybrid derivative 3,4-dihydroxy-N-[1-[2-(5-hydroxy-1H-indol-3-yl)-2-oxoethyl]piperidin-4-yl]benzamide (10) was the most effective antioxidant agent (>94.1 ± 0.1% of inhibition at 17 μM) and showed GluN2B/NMDA receptor affinity at low micromolar concentration (IC₅₀ 0.66 μM). By means of computational studies we explored the effect of the presence of this antioxidant fragment during the recognition process to binding pocket.

摘要

几种吲哚衍生物是高度有效的 GluN2B 亚基包含的 N-甲基-D-天冬氨酸 (NMDA) 受体配体,在 ABTS 法中也表现出抗氧化特性。特别是 2-(4-苄基哌啶-1-基)-1-(5-羟基-1H-吲哚-3-基)乙酮(1)被证明是一种双重有效的神经保护剂。为了提高抗氧化性能,我们将儿茶酚部分添加到哌啶部分上。设计的混合衍生物 3,4-二羟基-N-[1-[2-(5-羟基-1H-吲哚-3-基)-2-氧代乙基]哌啶-4-基]苯甲酰胺(10)是最有效的抗氧化剂(在 17 μM 时抑制率>94.1±0.1%),并在低微摩尔浓度下显示出 GluN2B/NMDA 受体亲和力(IC₅₀为 0.66 μM)。通过计算研究,我们探讨了在结合口袋识别过程中存在这种抗氧化片段的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验